BioCentury
ARTICLE | Clinical News

Esprolol: Began Phase IIb study

June 28, 1999 7:00 AM UTC

Selectus Pharmaceuticals Inc., West Conshohocken, Penn. Product: Esprolol Business: Cardiovascular Therapeutic category: Receptor antagonist Target: Beta adrenergic receptors Description: Sublingual ...